MX2015011540A - Solucion de electrolitos orales que contiene lactoferrina y usos de la misma. - Google Patents

Solucion de electrolitos orales que contiene lactoferrina y usos de la misma.

Info

Publication number
MX2015011540A
MX2015011540A MX2015011540A MX2015011540A MX2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A
Authority
MX
Mexico
Prior art keywords
electrolyte solution
lactoferrin
oral electrolyte
reducing
solution containing
Prior art date
Application number
MX2015011540A
Other languages
English (en)
Inventor
Juan M Gonzalez
John D Alvey
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2015011540A publication Critical patent/MX2015011540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C17/00—Buttermilk; Buttermilk preparations
    • A23C17/02—Buttermilk; Buttermilk preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una solución de electrolitos orales que comprende lactoferrina. La lactoferrina puede promover el sanado intestinal durante un ataque de diarrea en un sujeto pediátrico, reduciendo por esto la duración de los síntomas de la diarrea. Adicionalmente, las soluciones de electrolitos orales descritas aquí pueden comprender el Lactobacillus rhamnosus GG, la vitamina B3 y/o una fuente de zinc. La descripción se refiere además a métodos de reducción de la duración de los síntomas de la diarrea y de reducción de la irritación gastrointestinal en un sujeto pediátrico por la provisión de una solución de electrolitos orales que comprende lactoferrina.
MX2015011540A 2013-03-11 2014-02-11 Solucion de electrolitos orales que contiene lactoferrina y usos de la misma. MX2015011540A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/794,014 US20140255365A1 (en) 2013-03-11 2013-03-11 Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
PCT/US2014/015811 WO2014143471A1 (en) 2013-03-11 2014-02-11 Oral electrolyte solution containing lactoferrin and uses thereof

Publications (1)

Publication Number Publication Date
MX2015011540A true MX2015011540A (es) 2016-02-05

Family

ID=50239940

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011540A MX2015011540A (es) 2013-03-11 2014-02-11 Solucion de electrolitos orales que contiene lactoferrina y usos de la misma.

Country Status (14)

Country Link
US (1) US20140255365A1 (es)
EP (1) EP2968305A1 (es)
CN (1) CN105120888A (es)
AR (1) AR095082A1 (es)
AU (1) AU2014228654B2 (es)
BR (1) BR112015020864A2 (es)
CA (1) CA2904221A1 (es)
HK (1) HK1218070A1 (es)
MX (1) MX2015011540A (es)
PE (1) PE20151883A1 (es)
PH (1) PH12015501803A1 (es)
RU (1) RU2015132613A (es)
SG (1) SG11201505529SA (es)
WO (1) WO2014143471A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
GR1009632B (el) 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
NZ330484A (en) 1994-02-16 1999-11-29 Pharming Bv Isolation of lactoferrin especially recombinant lactoferrin from milk
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
NZ535784A (en) 2002-03-07 2006-02-24 Upfront Chromatography As A process of isolating lactoferrin
JP2009513572A (ja) * 2005-09-28 2009-04-02 ベントリア バイオサイエンス 腸管障害及び／又は下痢用の経口組成物
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
IT1392672B1 (it) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
US20120171328A1 (en) 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
HK1218070A1 (zh) 2017-02-03
AU2014228654B2 (en) 2018-02-15
WO2014143471A1 (en) 2014-09-18
CA2904221A1 (en) 2014-09-18
PE20151883A1 (es) 2016-01-17
SG11201505529SA (en) 2015-08-28
AU2014228654A1 (en) 2015-08-06
AR095082A1 (es) 2015-09-16
EP2968305A1 (en) 2016-01-20
BR112015020864A2 (pt) 2017-07-18
US20140255365A1 (en) 2014-09-11
CN105120888A (zh) 2015-12-02
PH12015501803A1 (en) 2015-11-09
RU2015132613A (ru) 2017-04-13

Similar Documents

Publication Publication Date Title
MX2021003370A (es) Estado de ayuno como tratamiento dietetico de la diabetes.
MX2012011161A (es) Sistemas, metodos y dispositivos de asistencia cardiaca de combinacion.
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
GB201020860D0 (en) Disulfiram formulation and uses thereof
MX365403B (es) Peptidos y metodos para usarlos.
BR112013011259A2 (pt) condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3
BR112016023752A2 (pt) utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
PH12016500025A1 (en) Methods for promoting neuronal development and/or health
PH12015501803A1 (en) Oral electrolyte solution containing lactoferrin and uses thereof
MX2016004328A (es) Inmunopotenciador.
MX351765B (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
PH12015500468B1 (en) Treatment and prevention of acne
RU2011122313A (ru) Способ цитологического исследования базального трахеобронхиального секрета у здоровых лиц при коррекции антиоксидантами воздействия низкой температуры окружающей среды на организм
NZ629711A (en) Anti-inflammatory compositions, methods and uses thereof
UA92875U (uk) Спосіб профілактики серцево-судинних захворювань
MX351517B (es) Solucion de electrolitos baja en calorias.
NZ767226A (en) Egg protein formulations and methods of manufacture thereof
TN2013000404A1 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
UA104124U (ru) Способ диагностики воспаления слизистой оболочки толстой кишки при синдроме раздраженного кишечника
UA90307U (uk) Спосіб лікування харчових отруєнь за допомогою яблучного оцту
UA103263C2 (ru) Способ увеличения полового члена и электромеханический экстендер для его реализации